Use the journals feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up
Journals
Cardiovascular Revascularizati...
Cardiovascular Revascularization Medicine : Including Molecular Interventions
#1
EDITORIAL
Spencer B King
No abstract text is available yet for this article.
August 30, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
#2
JOURNAL ARTICLE
Antonio L Bartorelli, Giovanni Monizzi, Luca Grancini, Emanuele Gallinoro, Angelo Mastrangelo, Vincenzo Mallia, Franco Fabbiocchi
BACKGROUND: Coronary bifurcation lesions (CBL) comprise 15 %-20 % of percutaneous coronary procedures and remain a challenge despite advances in stent and interventional techniques. The BioMime™ Branch sirolimus-eluting coronary side-branch stent (BBSES) is specifically designed for CBL treatment in conjunction with a standard drug-eluting stent (DES). We report the first single-center experience of treating complex CBL with the novel BBSES. METHODS: This is a retrospective, single-center study involving consecutive prospectively identified patients who underwent treatment of true CBL with the BBSES...
August 28, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
#3
JOURNAL ARTICLE
Axel Rentzsch, Eva Metz, Ruben Mühl-Benninghaus, Alexander Maßmann, Stephanie Bettink, Bruno Scheller, Lilia Lemke, Ali Awadelkareem, Toshiki Tomori, Ayman Haidar, Matthias W Laschke, Michael D Menger, Cenk Aktas, Matthias Hannig, Norbert Pütz, Thomas Büttner, David Scheschkewitz, Michael Veith, Hashim Abdul-Khaliq
BACKGROUND: Intima proliferation and in-stent restenosis is a challenging situation in interventional treatment of small vessel obstruction. Al/Al2 O3 nanowires have been shown to accelerate vascular endothelial cell proliferation and migration in vitro, while suppressing vascular smooth muscle cell growth. Moreover, surface modification of Al/Al2 O3 nanowires with poly[bis(2,2,2-trifluoromethoxy)phosphazene (PTFEP) coating enables further advantages such as reduced platelet adhesion...
August 24, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
#4
JOURNAL ARTICLE
Shreyash M Manegaonkar, Rishi Sukhija, Mohamed A Effat, Marepalli Rao, Rupak K Banerjee
BACKGROUND: Evaluating the severity of aortic stenosis (AS) can be challenging, particularly in patients with low-gradient (LG, Δp < 40 mmHg) AS. OBJECTIVE: This study aims to improve the accuracy of assessing severity of AS using a novel functional index- Aortic Valve Coefficient (AVC). The AVC is defined as ratio of mean transvalvular pressure-drop (Δp) to the proximal dynamic pressure (1/2 × blood density × VLVOT 2 ; VLVOT : left ventricular outflow tract peak velocity)...
August 22, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
#5
JOURNAL ARTICLE
Enrico Poletti, Ignacio Amat-Santos, Enrico Criscione, Antonio Popolo Rubbio, Mario García-Gómez, Mateusz Orzalkiewicz, Manuel Pan, Antonio Sisinni, Mattia Squillace, Bruno García Del Blanco, Francesco Bruno, Vasileios Panoulas, Radoslaw Pracon, Ole De Backer, Maurizio Taramasso, Giuliano Costa, Marco Barbanti, Nicolas M Van Mieghem, Damiano Regazzoli, Antonio Mangieri, Andrea Scotti, Azeem Latib, Francesco Saia, Francesco Bedogni, Luca Testa
BACKGROUND: The off-label utilization of transcatheter heart valve (THV) devices for the treatment of inoperable or high-surgical risk patients with pure native aortic valve regurgitation (NAVR) has demonstrated suboptimal outcomes, both with self- and balloon-expandable (BE) devices. The aim of this study is to compare the use of different BE scaffolds in treating pure NAVR. METHODS: Consecutive patients with pure severe NAVR who were deemed to be at high-risk and were treated with last-generation BE-THVs among seventeen Centers in Europe and US...
August 22, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
#6
EDITORIAL
Placido Maria Mazzone, Davide Capodanno
No abstract text is available yet for this article.
August 22, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
#7
EDITORIAL
David Gittess, R David Anderson
No abstract text is available yet for this article.
August 22, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
#8
JOURNAL ARTICLE
Gauravpal S Gill, Shikha Shailly, Teja Chakrala, Anirudh Palicherla, Pramod K Ponna, Venkata Mahesh Alla, Arun Kanmanthareddy
BACKGROUND: Chronic kidney disease (CKD) and end stage renal disease (ESRD) are associated with increased risk of bleeding events, including hemorrhagic stroke, and periprocedural and gastrointestinal bleeding among patients with atrial fibrillation who are on anticoagulation. Safety of percutaneous left atrial appendage occlusion (LAAO) among this patient population has been uncertain with studies showing contradictory results. METHODS: PubMed and Google Scholar databases were queried for studies comparing outcomes among patients with and without significant CKD, and with and without ESRD who underwent LAAO device implantation...
August 22, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
#9
JOURNAL ARTICLE
Giulio Piedimonte, Enrico Cerrato, Cristina Rolfo, Ivan J Nunez Gil, Lorenzo Azzalini, Riccardo Mangione, Francesco Maiellaro, Alberto Boi, Donovan Riganelli, Andrea Sardone, Francesco Bruno, Fernando Scudiero, Giampiero Vizzari, Gabriele Carciotto, Dario Calderone, Marco Borgi, Francesco Paolo Cancro, Ivan Sanchez, Massimo Leoncini, Emanuele Sagazio, Francesco Colombo, Gabriele Rosso, Tania Chechi, Simone Zecchino, Marco Pavani, Alfonso Franzè, Greca Zanda, Manuel Bosco, Jose Maria De La Torre Hernandez, Antonio Micari, Gennaro Galasso, Francesco Versaci, Corrado Tamburino, Giuseppe Patti, Alessio La Manna, Francesco Tomassini, Ferdinando Varbella
BACKGROUND: The optimal strategy during percutaneous coronary intervention (PCI) of aneurysmatic right coronary artery (ARCA) remains uncertain and has never been tested in the acute setting. OBJECTIVES: To compare the in-hospital and long-term outcomes of immediate and staged PCI strategies for ARCA as culprit lesions during acute coronary syndrome (ACS). METHODS: Among 102.376 PCIs performed in 18 European centers, a total of 85 patients presenting with acute coronary syndrome undergoing ARCA PCI were finally included in the analysis...
August 22, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
#10
EDITORIAL
Ezequiel J Molina
No abstract text is available yet for this article.
August 22, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
#11
JOURNAL ARTICLE
Keshav Patel, Melissa Duckett, Mladen I Vidovich, Khalil Ibrahim
INTRODUCTION: Intra-arterial (IA) vasodilators are recommended during transradial access (TRA) to prevent radial artery spasm (RAS). The American Heart Association (AHA) recommends either IA verapamil, diltiazem, nicardipine, or nitroglycerin to prevent RAS. To our knowledge, the efficacy of RAS prevention and patient tolerability of verapamil and nicardipine has not been directly compared in a randomized fashion. METHODS: We conducted a prospective, single-blinded randomized clinical trial comparing the discomfort experienced by patients receiving either 400 μg of IA nicardipine (n = 26) or 5 mg of IA verapamil (n = 29)...
August 20, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
#12
JOURNAL ARTICLE
Ahmad Jabri, Mohammed Ayyad, Maram Albandak, Ahmad Al-Abdouh, Luai Madanat, Basma Badrawy Khalefa, Laith Alhuneafat, Asem Ayyad, Alejandro Lemor, Mohammed Mhanna, Zaid Al Jebaje, Raef Fadel, Pedro Engel Gonzalez, Brian O'Neill, Rodrigo Bagur, Ivan D Hanson, Amr E Abbas, Tiberio Frisoli, James Lee, Dee Dee Wang, Vikas Aggarwal, Khaldoon Alaswad, William W O'Neill, Herbert D Aronow, Mohammad AlQarqaz, Pedro Villablanca
BACKGROUND: While transcatheter aortic valve replacement (TAVR) has broadened treatment options for critically ill patients, outcomes among those with concomitant cardiogenic shock (CS) are not well-explored. METHODS: We conducted a comprehensive search of major databases for studies comparing outcomes following TAVR in patients with and without CS since inception up to October 31, 2023. Our meta-analysis included five non-randomized observational. Dichotomous outcomes were assessed using the Mantel-Haenszel method (risk ratio, 95 % CI), and continuous outcomes were evaluated using mean difference and 95 % CI with the inverse variance method...
August 17, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
#13
JOURNAL ARTICLE
Abdilahi Mohamoud, Nadhem Abdallah, Abdirahman Wardhere, Mahmoud Ismayl
BACKGROUND: The impact of palliative care consultation on the management and outcomes of patients hospitalized with out-of-hospital cardiac arrest (OHCA) remains poorly understood. This study examined associations between palliative care consultation and in-hospital outcomes of patients hospitalized with OHCA, stratified by survival status. METHOD: This cross-sectional study used data from the National Inpatient Sample (2016-2021). Adult patients hospitalized with OHCA who received cardiopulmonary resuscitation were included...
August 17, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
#14
LETTER
Frederic Bouisset, Javier Escaned, Daniel Munhoz, Takuya Mizukami, Ruiko Seki, Carlos H Salazar, Jeroen Sonck, Nieves Gonzalo, Bernard De Bruyne, Carlos Collet
No abstract text is available yet for this article.
August 16, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
#15
JOURNAL ARTICLE
Michael Wilderman, Kazuya Tateishi, David O'Connor, Sophia Simonian, Anjali Ratnathicam, Kristen Cook, Lucius De Gregorio, Hosam Hmoud, Joseph De Gregorio
BACKGROUND: Large bore percutaneous access is becoming increasingly common. Parallel to this, we observe an increase in vascular access site complications such as bleeding, dissection, thrombosis or pseudo-aneurysms. This study was aimed to evaluate safety and efficacy of covered stent grafts for fixing large bore vascular access injuries. METHODS: A total of 147 Viabahn or Viabahn VBX (WL Gore) stent grafts which were placed across the inguinal ligament in emergent settings in 136 patients, were retrospectively analyzed...
August 16, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
#16
JOURNAL ARTICLE
Gianni Dall'Ara, Sara Piciucchi, Carolina Moretti, Caterina Cavazza, Miriam Compagnone, Giuseppe Guerrieri, Simone Grotti, Daniela Spartà, Roberto Carletti, Elisabetta Fabbri, Emanuela Giampalma, Andrea Santarelli, Filippo Ottani, Marco Balducelli, Francesco Saia, Fabio Felice Tarantino, Marcello Galvani
BACKGROUND: There is little data on the outcome of balloon aortic valvuloplasty (BAV) in relation to valve dimensions and calcification patterns. The procedure is not standardized, particularly the choice of balloon size. METHODS: This retrospective multicenter study focused on BAV efficacy and safety by analyzing the relationship between balloon size, annulus geometry (i.e., diameters, perimeter, and area), and calcification patterns (total burden and calcium distribution over each individual leaflet)...
August 16, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
#17
JOURNAL ARTICLE
Garry W Hamilton, Anoop N Koshy, Diem Dinh, Angela Brennan, Julian Yeoh, Matias B Yudi, Mark Horrigan, Christopher M Reid, Dion Stub, William Chan, Ernesto Oqueli, Melanie Freeman, Chin Hiew, Andrew Ajani, Omar Farouque, David J Clark
BACKGROUND: Guidelines and international appropriate use criteria increasingly endorse non-invasive stress testing to evaluate patients with suspected chronic coronary disease (CCD). We sought to review the real-world utilisation of non-invasive stress testing and investigate whether their use prior to PCI associates with outcomes in patients with CCD. METHODS: Consecutive patients from a multicentre registry who underwent PCI for CCD between 2006 and 2018 were included...
August 15, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
#18
JOURNAL ARTICLE
Yong-Hao Yeo, Jia-Yean Thong, Min-Choon Tan, Qi-Xuan Ang, Boon-Jian San, Bryan E-Xin Tan, Arka Chatterjee, Kwan Lee
BACKGROUND: While transcatheter edge-to-edge repair (TEER) with MitraClip is increasingly used, data on the risk stratification for assessing early mortality after this procedure are scarce. OBJECTIVE: This study aimed to assess early mortality and analyze the risk factors of early mortality among patients who underwent TEER. METHODS: Using the all-payer, nationally representative Nationwide Readmissions Database, our study included patients aged 18 years or older who had TEER between January 2017 and November 2020...
August 15, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
#19
JOURNAL ARTICLE
Antonio Mangier, Luca Testa, Tay M Heang, Irene Bossi, Chuey Y Lee, Ignacio S Perez, Diego Milazzo, Amin A Nuruddin, Giuseppe Seresini, Ramesh Singh, Michele Cacucci, Alessandro Sciahbasi, Alfonso Torres, Gunasekaran Sengottvelu, Antonio Colombo, Bernardo Cortese
BACKGROUND: Drug coated balloons (DCB) are potentially less thrombogenic than drug eluting stents (DES). AIMS: To explore the safety and the feasibility of single antiplatelet therapy in percutaneous coronary intervention with sirolimus-coated balloons. METHODS: The All-comers Sirolimus-coated Balloon European Registry (EASTBOURNE) is a prospective investigator-driven registry assessing the performance of a novel sirolimus-coated balloon (SCB) in a real-world population...
July 30, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
#20
EDITORIAL
Elena Bacigalupi, Matteo Perfetti, Marco Zimarino
No abstract text is available yet for this article.
July 29, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
